Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Explore innovative ways to earn income outside of traditional jobs. Open new doors to financial success!
23,859 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Disney escalates a high-stakes clash with the FCC as ABC stations face early license reviews. A $15 million payment t...
When authorities in Italy halted two high-profile concerts, fans and promoters faced more than disappointment. This g...
erin brockovich, activist defeated, pivots from courtroom wins to data-center transparency, unveiling a nationwide re...
Investors eye the Q4 2025 earnings transcript from Up Fintech (TIGR) to gauge growth, margins, and execution. This gu...
M&A chatter centers on mid-cap SaaS names ASAN, FRSH, and PD as buyers hunt for platform fit and durable ARR. Here’s ...
Apple readies its largest AI push at WWDC, centering on Siri and the iPhone as an AI gateway. The move could reshape ...
When a CFO buys a sizable block of shares, it can hint at confidence in the company’s future. This article breaks dow...
SoFi’s five-year arc has been a brutal test of conviction: a steep drawdown followed by a rebound as the fintech seek...
As AI reshapes tech investing, the question lingers: should chip stocks dip? This piece blends Jensen Huang’s long‑te...
Silver tumbled from peak, but the question remains: is the top silver ETF still worth a position? This guide breaks d...
A June breach hit Humanity Protocol’s H token on Ethereum and BNB Smart Chain, revealing key-management vulnerabiliti...